The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression.

The FDA says esketamine, an antidepressant derived from the anesthetic and party drug ketamine, can now be prescribed on its ...

On his first day in office, President Donald Trump announced plans to pull America from the Paris Agreement and expand the production of oil, both campaign promises.

A new paper led by Professor Imanuel Lerman of UC San Diego provides a review of the field of bioelectronic medicine and the most promising opportunities for life-changing new therapies and ...

The administration of U.S. President Donald Trump has instructed federal health agencies to pause all external communications ...

Some Trump insiders are ready to take on the food industry. It remains to be seen whether their entrée will result in any ...

Amid a deluge of executive actions, the Trump administration has asked federal health agencies to pause external ...

The U.S. Food and Drug Administration on Tuesday approved the first nasal spray that will help with treating major depressive ...

The Biden administration's eleventh-hour proposal to lower nicotine concentrations in cigarettes has led some Floridians to ...

On Tuesday, the U.S. Food and Drug Administration (FDA) placed a clinical hold on Atara Biotherapeutics, Inc.’s (NASDAQ:ATRA) ...

Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those ...

The FDA says vaping companies are improperly gaming the court system, filing claims in an appeals court they think will be sympathetic to them.